Erector Spinae Plane Block for Back Pain
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Erector Spinae Plane Block for back pain?
Is the Erector Spinae Plane Block generally safe for humans?
The Erector Spinae Plane Block is generally considered to have a favorable safety profile, but complications like priapism (a prolonged erection) and potential systemic toxicity have been reported. Large studies suggest few complications, but as its use increases, more side effects may be identified.26789
How is the erector spinae plane block treatment different from other treatments for back pain?
The erector spinae plane block is unique because it involves injecting a local anesthetic between muscle layers in the back to target the origin of spinal nerves, providing pain relief. This technique is relatively new and can be guided by ultrasound or fluoroscopy, making it a versatile option for managing both acute and chronic pain.310111213
What is the purpose of this trial?
The goal of this clinical trial is to learn if an erector spinae plane block (ESPB; a type of nerve block) works to reduce pain in adults presenting to the emergency department with low back pain. It will also learn if the ESPB reduces pain, disability, and return to work at 7 days. The main questions it aims to answer are:1. Does the ESPB reduce short-term pain in participants with low back pain?2. Does the ESPB reduce longer-term pain, reduce disability, and improve return to work and activities in participants with low back pain?Researchers will compare ESPB to a placebo (an injection that does not involve a nerve block) to see if ESPB works to treat low back pain.Participants will:Receive either the ESPB or a placebo injection in the emergency department Report their pain scores for up to 120 minutes Report their pain, disability, and return to work at 7 days
Research Team
Michael Gottlieb, MD
Principal Investigator
Rush University Medical Center
Eligibility Criteria
This trial is for adults over 18 who come to the emergency department with low back pain that's been there for less than six weeks. It's not specified, but typically people with certain health conditions or those on conflicting medications might be excluded.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the ESPB or a placebo injection in the emergency department
Immediate Follow-up
Participants report their pain scores for up to 120 minutes post-intervention
Follow-up
Participants report their pain, disability, and return to work at 7 days
Treatment Details
Interventions
- Erector Spinae Plane Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor